Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Glioblastoma 12Prostatic Neoplasms 11Breast Neoplasms 10Lung Neoplasms 9Carcinoma, Non-Small-Cell Lung 9Neoplasm Metastasis 7Squamous Cell Carcinoma of Head and Neck 6Sarcoma 5Oropharyngeal Neoplasms 5Neoplasms 4Histiocytoma, Malignant Fibrous 4Head and Neck Neoplasms 4Brain Neoplasms 4Astrocytoma 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Triple Negative Breast Neoplasms 3Sarcoma, Synovial 3Rhabdomyosarcoma 3Melanoma 3Liposarcoma 3Leiomyosarcoma 3Hodgkin Disease 3Esophageal Squamous Cell Carcinoma 3Carcinoma, Hepatocellular 3Adenocarcinoma Of Esophagus 3Stomach Neoplasms 2Sarcoma, Ewing 2Rhabdomyosarcoma, Embryonal 2Rhabdomyosarcoma, Alveolar 2

Interventions

Radiotherapy 1Radiation 1Platinum 1Cisplatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise Specified × Radiation × Clear all
NCT04580771 2026-04-15

A Vaccine (PDS0101) and Chemoradiation for the Treatment of Stage IB3-IVA Cervical Cancer, the IMMUNOCERV Trial

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
22 enrolled
Gynecologic

Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise Specified

Data powered by HemOnc (CC BY 4.0) Colophon âš¡